Luo J, Tannock I F
Department of Medicine, Ontario Cancer Institute, Toronto, Canada.
Br J Cancer. 1994 Oct;70(4):617-24. doi: 10.1038/bjc.1994.360.
The viability of cells within the acidic microenvironment found in solid tumours is expected to depend on the regulation of intracellular pH (pHi). 5-(N,N-hexamethylene) amiloride (HMA) is a potent inhibitor of the Na+/H+ antiport, a major mechanism for the regulation of pHi. We have therefore studied the cytotoxicity of HMA in combination with nigericin, a cell-acidifying agent, for EMT-6 cells in monolayer cell culture, in spheroids and in a murine tumour model. The combination of nigericin and HMA was toxic to cells in tissue culture at extracellular pH (pHe) < or = 6.8 (as may be found in tumours) but not at pH 7.0 or above (as in most normal tissues). Compared with amiloride, the relative potency of HMA in causing in vitro cytotoxicity (approximately 100-fold) was similar to that for inhibition of the Na+/H+ antiport. The fluorescent probe Hoechst 33342 was used with flow cytometry to study the cytotoxicity of HMA and nigericin at different depths in multicellular tumour spheroids. Only small differences in the level of cell survival were observed, but higher concentrations of HMA were required as compared with those giving equal levels of survival in monolayer culture. The pharmacokinetics of HMA in mice was studied by using high-performance liquid chromatography: after intraperitoneal injection of 20 micrograms g-1, the plasma level of HMA peaked at 8 microM after about 15 min and decreased to 1 microM at 120 min; the half-life was 35 min. Nigericin and HMA, at doses of 1.25 micrograms g-1 and 10 micrograms g-1 respectively, failed to cause significant cell killing in the EMT-6 murine tumour, but the surviving fraction was reduced to approximately 0.004 when hydralazine was administered with nigericin and HMA. Local tumour irradiation (15 Gy), followed by treatment with these drugs, led to cell killing that was additive to the effects of drugs and radiation alone, so that hypoxic cells which survived radiation did not appear more sensitive to pH-dependent drug treatment. Acid-mediated therapy can lead to cell death in murine solid tumours, but further measures will be required before the strategy can be exploited clinically.
实体瘤中酸性微环境下细胞的生存能力预计取决于细胞内pH值(pHi)的调节。5-(N,N-六亚甲基)氨氯吡脒(HMA)是Na+/H+逆向转运蛋白的强效抑制剂,而Na+/H+逆向转运蛋白是调节pHi的主要机制。因此,我们研究了HMA与尼日利亚菌素(一种细胞酸化剂)联合使用对单层细胞培养、球体培养及小鼠肿瘤模型中EMT-6细胞的细胞毒性。尼日利亚菌素与HMA的联合使用在细胞外pH值(pHe)≤6.8(肿瘤中可能出现的情况)时对组织培养中的细胞有毒性,但在pH值为7.0或更高时(如大多数正常组织中)则无毒性。与氨氯吡脒相比,HMA在体外引起细胞毒性的相对效力(约100倍)与抑制Na+/H+逆向转运蛋白的效力相似。使用荧光探针Hoechst 33342结合流式细胞术研究了HMA和尼日利亚菌素在多细胞肿瘤球体不同深度的细胞毒性。仅观察到细胞存活水平的微小差异,但与单层培养中产生相同存活水平所需的浓度相比,需要更高浓度的HMA。通过高效液相色谱法研究了HMA在小鼠体内的药代动力学:腹腔注射20μg g-1后,HMA的血浆水平在约15分钟时达到峰值8μM,在120分钟时降至1μM;半衰期为35分钟。尼日利亚菌素和HMA的剂量分别为1.25μg g-1和10μg g-1时,未能在EMT-6小鼠肿瘤中引起显著的细胞杀伤,但当肼屈嗪与尼日利亚菌素和HMA联合使用时,存活分数降至约0.004。局部肿瘤照射(15 Gy)后再用这些药物治疗,导致的细胞杀伤作用是药物和辐射单独作用的累加效应,因此辐射后存活的缺氧细胞对pH依赖性药物治疗似乎并不更敏感。酸介导的疗法可导致小鼠实体瘤中的细胞死亡,但在该策略能够用于临床之前还需要采取进一步措施。